MLKL and Alzheimer disease: Interestingly, neurons treated with AD AEVs showed increased levels of the necroptosis marker phosphorylated MLKL, in comparison to control AEVs (Figure 4c,d), providing evidence for necroptosis activation that is consistent with, although not pathognomonic of, a mechanism of MAC-mediated neurotoxicity.